<?xml version="1.0" encoding="UTF-8"?>
<p id="para0083">Aviptadil is a vasoactive intestinal polypeptide (VIP) which is administered in Europe to treat erectile dysfunction. According to the results, aviptadil could be highly concentrated in the lung also it could block inflammatory cytokines. This drug has been received US and EU orphan drug designation to treat ARDS. Aviptadil received FDA approval phase II clinical trial in patients with COVID-19-related ARDS. This study was done on severe cases of COVID-19 who were on mechanical ventilation.
 <xref rid="bib0078" ref-type="bibr">
  <sup>78</sup>
 </xref>
</p>
